Issue 13/2012
Content (7 Articles)
Developing New Drugs for Diabetes and Cardiometabolic Disorders
- Editorial
Andrew J. Krentz, Linda Morrow, Marcus Hompesch
Will Abuse-Deterrent Formulations of Opioid Analgesics Be Successful in Achieving Their Purpose?
- Current Opinion
Bernard Bannwarth
Polymorphisms of Estrogen Receptors and Risk of Depression
- Leading Article
Joanne Ryan, Marie-Laure Ancelin
New Oral Anticoagulants
- Review Article
Birgitte Klindt Poulsen, Erik Lerkevang Grove, Steen Elkjaer Husted
Prevention of Venous Thromboembolism with New Oral Anticoagulants versus Standard Pharmacological Treatment in Acute Medically Ill Patients
- Systematic Review
Ida Ehlers Albertsen, Torben Bjerregaard Larsen, Lars Hvilsted Rasmussen, Thure Filskov Overvad, Gregory Y. H. Lip
Reduced-Antigen, Combined Diphtheria, Tetanus and Acellular Pertussis Vaccine, Adsorbed (Boostrix®)
- Adis Drug Evaluation
Paul L. McCormack